Asthma
Asthma
• Laboratory assessments and studies are not routinely indicated for the
diagnosis of asthma, but they may be used to exclude other diagnoses.
Eosinophilia and elevated serum IgE levels may help guide therapy in
some cases.
• Arterial blood gases and pulse oximetry are valuable for assessing
severity of exacerbations and following response to treatment.
• Spirometry with post bronchodilator response should be obtained as the
primary test to establish the asthma diagnosis.
• The chest radiograph remains the initial imaging evaluation in most
individuals with symptoms of asthma, but in most patients with asthma,
chest radiography findings are normal or may indicate hyperinflation.
Treatment
Pharmacologic treatment
• Pharmacologic management includes the use of relief and control
agents. Control agents include inhaled corticosteroids, long-acting
bronchodilators (beta-agonists and anticholinergics), theophylline
(Theo-24, Theochron, Uniphyl), leukotriene modifiers, anti-IgE
antibodies, anti-interleukin (IL)–5 antibodies, and anti–IL-4/IL-13
antibodies. Relief medications include short-acting bronchodilators,
systemic corticosteroids, and ipratropium (Atrovent).
• The pharmacologic treatment of asthma is based on stepwise therapy.
Asthma medications should be added or deleted as the frequency and
severity of the patient's symptoms change.
Allergen avoidance
• Environmental exposures and irritants can play a strong role in
symptom exacerbations. The use of skin testing or in vitro testing to
assess sensitivity to perennial indoor allergens is important. Once the
offending allergens are identified, counsel patients on how to avoid
them. Efforts should focus on the home, where specific triggers
include dust mites, animals, cockroaches, mold, and pollen.